• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原癌基因Ron可变剪接的调控RNA鉴定

Identification of Regulatory-RNAs for Alternative Splicing of Ron Proto-Oncogene.

作者信息

Moon Heegyum, Zheng Xuexiu, Loh Tiing Jen, Jang Ha Na, Liu Yongchao, Jung Da-Woon, Williams Darren R, Shen Haihong

机构信息

1These authors contributed equally to this manuscript.

School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.

出版信息

J Cancer. 2015 Nov 1;6(12):1346-51. doi: 10.7150/jca.13361. eCollection 2015.

DOI:10.7150/jca.13361
PMID:26640595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4643091/
Abstract

RON receptor tyrosine kinase is a proto-oncogene that induces cell migration and matrix invasion. RONΔ160 protein, which is produced by exclusion of exon 5 and 6, promotes cell migration, matrix invasion and protection from apoptosis. Alternative splicing regulation of exon 5 and 6 is not well understood. In this manuscript, we identified several new RNA regulatory elements for alternative splicing of Ron proto-oncogene. Firstly, we demonstrated that RNA sequences from EcoRI cleavage sites regulate alternative splicing of Ron exon 5 and 6. Secondly, we showed that the ~30 nt RNA at upstream end of exon 4 and the ~33 nt RNA at downstream end of exon 7 also modulate splicing of exon 5 and 6. Thirdly, our results indicate that the RNA sequences of the ends in exon 4 and 7 are required for the regulatory functions of the RNA from restriction enzyme cleavage sites. Our results provide a new insight for regulation of alternative splicing of Ron proto-oncogene.

摘要

RON受体酪氨酸激酶是一种原癌基因,可诱导细胞迁移和基质侵袭。通过外显子5和6的缺失产生的RONΔ160蛋白可促进细胞迁移、基质侵袭并保护细胞免受凋亡。外显子5和6的可变剪接调控尚未完全明确。在本论文中,我们鉴定了几种新的用于Ron原癌基因可变剪接的RNA调控元件。首先,我们证明来自EcoRI切割位点的RNA序列可调控Ron外显子5和6的可变剪接。其次,我们表明外显子4上游末端约30 nt的RNA和外显子7下游末端约33 nt的RNA也可调节外显子5和6的剪接。第三,我们的结果表明外显子4和7末端的RNA序列对于来自限制酶切割位点的RNA的调控功能是必需的。我们的结果为Ron原癌基因可变剪接的调控提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf1/4643091/9bda4037f0f4/jcav06p1346g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf1/4643091/48d304e248a9/jcav06p1346g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf1/4643091/3effc009b827/jcav06p1346g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf1/4643091/9bda4037f0f4/jcav06p1346g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf1/4643091/48d304e248a9/jcav06p1346g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf1/4643091/3effc009b827/jcav06p1346g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf1/4643091/9bda4037f0f4/jcav06p1346g003.jpg

相似文献

1
Identification of Regulatory-RNAs for Alternative Splicing of Ron Proto-Oncogene.原癌基因Ron可变剪接的调控RNA鉴定
J Cancer. 2015 Nov 1;6(12):1346-51. doi: 10.7150/jca.13361. eCollection 2015.
2
SRSF2 promotes splicing and transcription of exon 11 included isoform in Ron proto-oncogene.SRSF2促进原癌基因Ron中包含外显子11的异构体的剪接和转录。
Biochim Biophys Acta. 2014 Nov;1839(11):1132-40. doi: 10.1016/j.bbagrm.2014.09.003. Epub 2014 Sep 8.
3
A 2-nt RNA enhancer on exon 11 promotes exon 11 inclusion of the Ron proto-oncogene.A 2-nt RNA 增强子在第 11 外显子上促进 Ron 原癌基因第 11 外显子的包含。
Oncol Rep. 2014 Jan;31(1):450-5. doi: 10.3892/or.2013.2835. Epub 2013 Nov 5.
4
Exon Definition Facilitates Reliable Control of Alternative Splicing in the RON Proto-Oncogene.外显子定义促进 RON 原癌基因中可变剪接的可靠控制。
Biophys J. 2020 Apr 21;118(8):2027-2041. doi: 10.1016/j.bpj.2020.02.022. Epub 2020 Mar 3.
5
Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis.利用高通量诱变技术对 RON 原癌基因中的一个与癌症相关的剪接决定进行解码。
Nat Commun. 2018 Aug 17;9(1):3315. doi: 10.1038/s41467-018-05748-7.
6
Identification of novel splicing variants from RON proto-oncogene pre-mRNA.鉴定 RON 原癌基因前 mRNA 的新型剪接变异体。
Oncol Rep. 2012 Dec;28(6):2217-20. doi: 10.3892/or.2012.2043. Epub 2012 Sep 18.
7
RRM but not the Asp/Glu domain of hnRNP C1/C2 is required for splicing regulation of Ron exon 11 pre-mRNA.RRM 结构域而非 hnRNP C1/C2 的 Asp/Glu 结构域,对于 Ron 外显子 11 前体 mRNA 的剪接调控是必需的。
BMB Rep. 2019 Nov;52(11):641-646. doi: 10.5483/BMBRep.2019.52.11.080.
8
RON alternative splicing regulation in primary ovarian cancer.原发性卵巢癌中RON可变剪接调控
Oncol Rep. 2015 Jul;34(1):423-30. doi: 10.3892/or.2015.3995. Epub 2015 May 19.
9
Effects of PTCs on nonsense-mediated mRNA decay are dependent on PTC location.无义密码子对无义介导的mRNA降解的影响取决于无义密码子的位置。
Oncol Lett. 2017 Mar;13(3):1944-1948. doi: 10.3892/ol.2017.5627. Epub 2017 Jan 19.
10
Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives.Ron 原癌基因 mRNA 的促转移剪接可以逆转:双功能寡核苷酸和吲哚衍生物的治疗潜力。
RNA Biol. 2010 Jul-Aug;7(4):495-503. doi: 10.4161/rna.7.4.12744. Epub 2010 Jul 1.

引用本文的文献

1
SIRT5-modified human umbilical cord mesenchymal stem cells loaded with antioxidant polydopamine nanozyme enhance parpi resistance in ovarian cancer via fatty acid metabolism reprogramming.负载抗氧化聚多巴胺纳米酶的SIRT5修饰人脐带间充质干细胞通过脂肪酸代谢重编程增强卵巢癌对PARPi的抗性。
J Nanobiotechnology. 2025 Jul 4;23(1):485. doi: 10.1186/s12951-025-03516-6.

本文引用的文献

1
SRSF2 promotes splicing and transcription of exon 11 included isoform in Ron proto-oncogene.SRSF2促进原癌基因Ron中包含外显子11的异构体的剪接和转录。
Biochim Biophys Acta. 2014 Nov;1839(11):1132-40. doi: 10.1016/j.bbagrm.2014.09.003. Epub 2014 Sep 8.
2
PSF contacts exon 7 of SMN2 pre-mRNA to promote exon 7 inclusion.PSF与SMN2前体mRNA的外显子7结合,以促进外显子7的包含。
Biochim Biophys Acta. 2014 Jun;1839(6):517-25. doi: 10.1016/j.bbagrm.2014.03.003. Epub 2014 Mar 14.
3
HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition.
hnRNP A1 控制着一个剪接调控回路,促进间充质到上皮的转变。
Nucleic Acids Res. 2013 Oct;41(18):8665-79. doi: 10.1093/nar/gkt579. Epub 2013 Jul 17.
4
Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.新型可溶性 RON 形式通过包含整个 Sema 序列抑制癌细胞中的 MSP-RON 信号通路。
Int J Oncol. 2010 Jun;36(6):1551-61. doi: 10.3892/ijo_00000642.
5
Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.源自南特的酪氨酸激酶受体是缺氧诱导因子-1α介导的乳腺癌细胞侵袭的直接靶点。
J Biol Chem. 2009 May 22;284(21):14001-10. doi: 10.1074/jbc.M809320200. Epub 2009 Mar 23.
6
The spliceosome: design principles of a dynamic RNP machine.剪接体:一种动态核糖核蛋白机器的设计原理
Cell. 2009 Feb 20;136(4):701-18. doi: 10.1016/j.cell.2009.02.009.
7
An exonic splicing silencer represses spliceosome assembly after ATP-dependent exon recognition.外显子剪接沉默子在ATP依赖的外显子识别后抑制剪接体组装。
Nat Struct Mol Biol. 2006 Oct;13(10):937-44. doi: 10.1038/nsmb1149. Epub 2006 Sep 24.
8
Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene.细胞运动性由SF2/ASF通过Ron原癌基因的可变剪接来控制。
Mol Cell. 2005 Dec 22;20(6):881-90. doi: 10.1016/j.molcel.2005.10.026.
9
Mechanisms of cytoplasmic {beta}-catenin accumulation and its involvement in tumorigenic activities mediated by oncogenic splicing variant of the receptor originated from Nantes tyrosine kinase.细胞质β-连环蛋白积累的机制及其在由源自南特酪氨酸激酶受体的致癌剪接变体介导的致瘤活性中的作用。
J Biol Chem. 2005 Jul 1;280(26):25087-94. doi: 10.1074/jbc.M414699200. Epub 2005 May 6.
10
Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential.原发性人类结肠直肠癌中RON受体酪氨酸激酶的表达改变:不同剪接的RON变体的产生及其致癌潜力。
Oncogene. 2003 Jan 16;22(2):186-97. doi: 10.1038/sj.onc.1206075.